SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma files ANDA for Fingolimod with US FDA

10 Feb 2015 Evaluate

Natco Pharma has filed Abbreviated New Drug Applications (ANDAs) for Fingolimod, 0.5mg Capsules & Cabazitaxel, 60mg/1.5ml Injection, with the US Federal Drug Administration (US FDA), through its respective marketing partners in the USA.

Natco & its associated marketing partners, for the above products in the USA, are the first company to have filed a substantially complete ANDA which includes a paragraph IV certification for Fingolimod, 0.5mg Capsules & Cabazitaxel, 60mg/1.5ml Injection, providing 180 days of marketing exclusivity upon its final US FDA approval.

Novartis sells Fingolimod 0.5mg Capsules under Brand name Gilenya, in the USA market and used for the treatment of certain patients with multiple sclerosis. The market size of Gilenya in the USA is around $1.2 billion for twelve months ending September 2014.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

1124.40 5.45 (0.49%)
20-Apr-2026 09:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.60
Dr. Reddys Lab 1232.65
Cipla 1242.10
Zydus Lifesciences 944.25
Lupin 2328.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×